Cargando…

Quantitative Assessment of the Sensitivity of Various Commercial Reverse Transcriptases Based on Armored HIV RNA

BACKGROUND: The in-vitro reverse transcription of RNA to its complementary DNA, catalyzed by the enzyme reverse transcriptase, is the most fundamental step in the quantitative RNA detection in genomic studies. As such, this step should be as analytically sensitive, efficient and reproducible as poss...

Descripción completa

Detalles Bibliográficos
Autores principales: Okello, John B. A., Rodriguez, Linda, Poinar, Debi, Bos, Kirsten, Okwi, Andrew L., Bimenya, Gabriel S., Sewankambo, Nelson K., Henry, Kenneth R., Kuch, Melanie, Poinar, Hendrik N.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978101/
https://www.ncbi.nlm.nih.gov/pubmed/21085668
http://dx.doi.org/10.1371/journal.pone.0013931
_version_ 1782191214089469952
author Okello, John B. A.
Rodriguez, Linda
Poinar, Debi
Bos, Kirsten
Okwi, Andrew L.
Bimenya, Gabriel S.
Sewankambo, Nelson K.
Henry, Kenneth R.
Kuch, Melanie
Poinar, Hendrik N.
author_facet Okello, John B. A.
Rodriguez, Linda
Poinar, Debi
Bos, Kirsten
Okwi, Andrew L.
Bimenya, Gabriel S.
Sewankambo, Nelson K.
Henry, Kenneth R.
Kuch, Melanie
Poinar, Hendrik N.
author_sort Okello, John B. A.
collection PubMed
description BACKGROUND: The in-vitro reverse transcription of RNA to its complementary DNA, catalyzed by the enzyme reverse transcriptase, is the most fundamental step in the quantitative RNA detection in genomic studies. As such, this step should be as analytically sensitive, efficient and reproducible as possible, especially when dealing with degraded or low copy RNA samples. While there are many reverse transcriptases in the market, all claiming to be highly sensitive, there is need for a systematic independent comparison of their applicability in quantification of rare RNA transcripts or low copy RNA, such as those obtained from archival tissues. METHODOLOGY/PRINCIPAL FINDINGS: We performed RT-qPCR to assess the sensitivity and reproducibility of 11 commercially available reverse transcriptases in cDNA synthesis from low copy number RNA levels. As target RNA, we used a serially known number of Armored HIV RNA molecules, and observed that 9 enzymes we tested were consistently sensitive to ∼1,000 copies, seven of which were sensitive to ∼100 copies, while only 5 were sensitive to ∼10 RNA template copies across all replicates tested. Despite their demonstrated sensitivity, these five best performing enzymes (Accuscript, HIV-RT, M-MLV, Superscript III and Thermoscript) showed considerable variation in their reproducibility as well as their overall amplification efficiency. Accuscript and Superscript III were the most sensitive and consistent within runs, with Accuscript and Superscript II ranking as the most reproducible enzymes between assays. CONCLUSIONS/SIGNIFICANCE: We therefore recommend the use of Accuscript or Superscript III when dealing with low copy number RNA levels, and suggest purification of the RT reactions prior to downstream applications (eg qPCR) to augment detection. Although the results presented in this study were based on a viral RNA surrogate, and applied to nucleic acid lysates derived from archival formalin-fixed paraffin embedded tissue, their relative performance on RNA obtained from other tissue types may vary, and needs future evaluation.
format Text
id pubmed-2978101
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29781012010-11-17 Quantitative Assessment of the Sensitivity of Various Commercial Reverse Transcriptases Based on Armored HIV RNA Okello, John B. A. Rodriguez, Linda Poinar, Debi Bos, Kirsten Okwi, Andrew L. Bimenya, Gabriel S. Sewankambo, Nelson K. Henry, Kenneth R. Kuch, Melanie Poinar, Hendrik N. PLoS One Research Article BACKGROUND: The in-vitro reverse transcription of RNA to its complementary DNA, catalyzed by the enzyme reverse transcriptase, is the most fundamental step in the quantitative RNA detection in genomic studies. As such, this step should be as analytically sensitive, efficient and reproducible as possible, especially when dealing with degraded or low copy RNA samples. While there are many reverse transcriptases in the market, all claiming to be highly sensitive, there is need for a systematic independent comparison of their applicability in quantification of rare RNA transcripts or low copy RNA, such as those obtained from archival tissues. METHODOLOGY/PRINCIPAL FINDINGS: We performed RT-qPCR to assess the sensitivity and reproducibility of 11 commercially available reverse transcriptases in cDNA synthesis from low copy number RNA levels. As target RNA, we used a serially known number of Armored HIV RNA molecules, and observed that 9 enzymes we tested were consistently sensitive to ∼1,000 copies, seven of which were sensitive to ∼100 copies, while only 5 were sensitive to ∼10 RNA template copies across all replicates tested. Despite their demonstrated sensitivity, these five best performing enzymes (Accuscript, HIV-RT, M-MLV, Superscript III and Thermoscript) showed considerable variation in their reproducibility as well as their overall amplification efficiency. Accuscript and Superscript III were the most sensitive and consistent within runs, with Accuscript and Superscript II ranking as the most reproducible enzymes between assays. CONCLUSIONS/SIGNIFICANCE: We therefore recommend the use of Accuscript or Superscript III when dealing with low copy number RNA levels, and suggest purification of the RT reactions prior to downstream applications (eg qPCR) to augment detection. Although the results presented in this study were based on a viral RNA surrogate, and applied to nucleic acid lysates derived from archival formalin-fixed paraffin embedded tissue, their relative performance on RNA obtained from other tissue types may vary, and needs future evaluation. Public Library of Science 2010-11-10 /pmc/articles/PMC2978101/ /pubmed/21085668 http://dx.doi.org/10.1371/journal.pone.0013931 Text en Okello et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Okello, John B. A.
Rodriguez, Linda
Poinar, Debi
Bos, Kirsten
Okwi, Andrew L.
Bimenya, Gabriel S.
Sewankambo, Nelson K.
Henry, Kenneth R.
Kuch, Melanie
Poinar, Hendrik N.
Quantitative Assessment of the Sensitivity of Various Commercial Reverse Transcriptases Based on Armored HIV RNA
title Quantitative Assessment of the Sensitivity of Various Commercial Reverse Transcriptases Based on Armored HIV RNA
title_full Quantitative Assessment of the Sensitivity of Various Commercial Reverse Transcriptases Based on Armored HIV RNA
title_fullStr Quantitative Assessment of the Sensitivity of Various Commercial Reverse Transcriptases Based on Armored HIV RNA
title_full_unstemmed Quantitative Assessment of the Sensitivity of Various Commercial Reverse Transcriptases Based on Armored HIV RNA
title_short Quantitative Assessment of the Sensitivity of Various Commercial Reverse Transcriptases Based on Armored HIV RNA
title_sort quantitative assessment of the sensitivity of various commercial reverse transcriptases based on armored hiv rna
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978101/
https://www.ncbi.nlm.nih.gov/pubmed/21085668
http://dx.doi.org/10.1371/journal.pone.0013931
work_keys_str_mv AT okellojohnba quantitativeassessmentofthesensitivityofvariouscommercialreversetranscriptasesbasedonarmoredhivrna
AT rodriguezlinda quantitativeassessmentofthesensitivityofvariouscommercialreversetranscriptasesbasedonarmoredhivrna
AT poinardebi quantitativeassessmentofthesensitivityofvariouscommercialreversetranscriptasesbasedonarmoredhivrna
AT boskirsten quantitativeassessmentofthesensitivityofvariouscommercialreversetranscriptasesbasedonarmoredhivrna
AT okwiandrewl quantitativeassessmentofthesensitivityofvariouscommercialreversetranscriptasesbasedonarmoredhivrna
AT bimenyagabriels quantitativeassessmentofthesensitivityofvariouscommercialreversetranscriptasesbasedonarmoredhivrna
AT sewankambonelsonk quantitativeassessmentofthesensitivityofvariouscommercialreversetranscriptasesbasedonarmoredhivrna
AT henrykennethr quantitativeassessmentofthesensitivityofvariouscommercialreversetranscriptasesbasedonarmoredhivrna
AT kuchmelanie quantitativeassessmentofthesensitivityofvariouscommercialreversetranscriptasesbasedonarmoredhivrna
AT poinarhendrikn quantitativeassessmentofthesensitivityofvariouscommercialreversetranscriptasesbasedonarmoredhivrna